September 2025
1. BERTRAND A, Meyer A, Kirchgesner J, Uzzan M, et al
   Effectiveness and safety of third-line advanced therapies in patients with ulcerative colitis: A multicentre retrospective cohort study: Third-line treatment in UC.
   Clin Res Hepatol Gastroenterol. 2025 Sep 29:102699.
   

   >> Share

   
   
2. YZET C, Robert C, Brazier F, Meudjo E, et al
   Impact of histological healing on ulcerative colitis disease course among patients with endoscopic healing: results of a prospective study.
   Clin Res Hepatol Gastroenterol. 2025;49:102700.
   

   >> Share

   
   
3. TATOUR M, Baker FA, Saadi T, Hazzan R, et al
   Long-Term Risk of Inflammatory Bowel Disease in Autoimmune Hepatitis: over a 20-Year Population-Based Study.
   Clin Res Hepatol Gastroenterol. 2025 Sep 6:102682.
   

   >> Share

   
   
4. DUQUEROIS AS, Martinez-Vinson C, Loppinet T, Restier L, et al
   A series of pediatric patients with inflammatory bowel disease switching from intravenous to subcutaneous infliximab maintenance therapy.
   Clin Res Hepatol Gastroenterol. 2025;49:102680.
   

   >> Share

   
   August 2025
5. PASI G, Antari A, Masson D, Dejoie T, et al
   Improving Fecal Sample Collection in Patients with Inflammatory Bowel Disease: A Comparative Evaluation of Two Calprotectin Devices.
   Clin Res Hepatol Gastroenterol. 2025 Aug 2:102665.
   

   >> Share

   
   July 2025
6. KIRCHGESNER J, Augustin J, Bazin T, Freiha P, et al
   A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis.
   Clin Res Hepatol Gastroenterol. 2025;49:102615.
   

   >> Share

   
   June 2025
7. MARTEAU P, Calmus Y
   The triple association of Sickle cell Disease, primary sclerosing cholangitis and inflammatory bowel disease (SCD-PSC-IBD): iceberg in sight.
   Clin Res Hepatol Gastroenterol. 2025 Jun 4:102633.
   

   >> Share

   
   April 2025
8. MARTEAU P
   Effectiveness of medical treatments depending on Crohn's disease location. That is the question.
   Clin Res Hepatol Gastroenterol. 2025 Apr 17:102597.
   

   >> Share

   
   
9. CHEN M, Gao X, Cao Q, Rossiter G, et al
   Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease.
   Clin Res Hepatol Gastroenterol. 2025 Apr 12:102591.
   

   >> Share

   
   
10. DERMINE S, Bazin T, Hassan FA, Bettolo J, et al
    Prevalence and impact of sarcopenia in patients with inflammatory bowel diseases: A prospective cohort study.
    Clin Res Hepatol Gastroenterol. 2025;49:102555.
    

    >> Share

    
    March 2025
11. SHAH N, Gupta K, Rustgi V, Minacapelli C, et al
    Non-obstructive Sinusoidal Dilation in Inflammatory Bowel Disease.
    Clin Res Hepatol Gastroenterol. 2025 Mar 19:102576.
    

    >> Share

    
    February 2025
12. BOVE L, Meyer J, Collins M, Frampas E, et al
    Understanding the learning curve of intestinal ultrasound in inflammatory bowel disease: A comparative study between novice, regular and expert.
    Clin Res Hepatol Gastroenterol. 2025;49:102548.
    

    >> Share

    
    
13. DUBIAN S, Yzet C, Brazier F, Yzet T, et al
    Fecal calprotectin, intestinal ultrasound, and their combination for the diagnosis of inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2025 Feb 3:102549.
    

    >> Share

    
    January 2025
14. DE CASTELBAJAC F, Billet N, Monnier-Chollet L, Zaanan A, et al
    An ileo-anal pouch doing the twist (with video).
    Clin Res Hepatol Gastroenterol. 2025;49:102511.
    

    >> Share

    
    December 2024
15. ZIMMER V
    The flaming and pulled up anorectal line: Ulcerative colitis-associated squamous metaplasia of the lower rectum.
    Clin Res Hepatol Gastroenterol. 2024;49:102513.
    

    >> Share

    
    
16. LAHARIE D, Bouhnik Y, Vuitton L, Biron A, et al
    Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study).
    Clin Res Hepatol Gastroenterol. 2024;48:102483.
    

    >> Share

    
    November 2024
17. SOUAID C, Fares E, Primard P, Macaigne G, et al
    A Review Investigating delays in Crohn's disease diagnosis.
    Clin Res Hepatol Gastroenterol. 2024 Nov 15:102500.
    

    >> Share

    
    September 2024
18. ALONSO-GOMEZ M, Charlois AL, Cotte E, Gay C, et al
    Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102473.
    

    >> Share

    
    
19. RODRIGUES IC, Dibombe L, Guillouche P, Matysiak-Budnik T, et al
    Adenosquamous intrahepatic cholangiocarcinoma in a patient with primary sclerosing cholangitis and ulcerative colitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102471.
    

    >> Share

    
    
20. SHI J, Ji S, Xu M, Wang Y, et al
    Selenium inhibits ferroptosis in ulcerative colitis through the induction of Nrf2/Gpx4.
    Clin Res Hepatol Gastroenterol. 2024;48:102467.
    

    >> Share

    
    
21. XIAO F, Wei Y, Zou P, Wu X, et al
    Associations between single and combined exposures to environmental phenols and ulcerative colitis in American adults.
    Clin Res Hepatol Gastroenterol. 2024;48:102468.
    

    >> Share

    
    
22. LU B, Zhang M, Wang Z, Zhang W, et al
    Development of a nomogram for postoperative surgical site infections in patients undergoing bowel resection for Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102462.
    

    >> Share

    
    August 2024
23. LI R
    Thirty-day outcomes of non-emergent colectomy for inflammatory bowel disease in patients with chronic obstructive pulmonary disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102445.
    

    >> Share

    
    
24. ZHANG H, Zheng H, Wang Q, Ma Z, et al
    Sinomenine hydrochloride improves DSS-induced colitis in mice through inhibition of the TLR2/NF-kappaB signaling pathway.
    Clin Res Hepatol Gastroenterol. 2024;48:102411.
    

    >> Share

    
    May 2024
25. YZET C, Brazier F, Hautefeuille V, Richard N, et al
    Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: a cross-sectional study.
    Clin Res Hepatol Gastroenterol. 2024 May 27:102387.
    

    >> Share

    
    
26. VERMEIRE S, Dubinsky MC, Rabizadeh S, Panetta JC, et al
    Forecasted Infliximab Concentrations During Induction Predict Time to Remission and Sustained Disease Control of Inflammatory Bowel Disease.
    Clin Res Hepatol Gastroenterol. 2024 May 13:102374.
    

    >> Share

    
    March 2024
27. YANG J, Huang MMC, Liang MMJ, Lei MMY, et al
    The diagnostic performance of serum alphavbeta6 autoantibodies for ulcerative colitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2024;48:102317.
    

    >> Share

    
    December 2023
28. GRELLIER N, Sokol H, Seksik P
    Gut dysbiosis in Crohn's disease: never so close to solving the chicken-and-egg enigma: Commentary to "Gut Microbiome Composition Is Associated with Future Onset of Crohn's Disease in Healthy First-Degree Relatives, by Raygoza Garay JA et al., Gastroe
    Clin Res Hepatol Gastroenterol. 2023 Dec 23:102272.
    

    >> Share

    
    November 2023
29. KAKDIYA R, Jha DK, Choudhury A, Jena A, et al
    Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023 Nov 23:102250.
    

    >> Share

    
    
30. UZZAN M, Assouline V, Chambenois E, Djabbari M, et al
    Focal loss of mural stratification as a radiological predictor for small bowel adenocarcinoma in Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2023 Nov 13:102246.
    

    >> Share

    
    September 2023
31. ZHANG C, Liu X
    Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102214.
    

    >> Share

    
    June 2023
32. JENA A, Neelam PB, Telaprolu H, Mangipudi UK, et al
    Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression.
    Clin Res Hepatol Gastroenterol. 2023 Jun 8:102155.
    

    >> Share

    
    April 2023
33. DAR SH, Maniya MT, Merza N, Musheer A, et al
    The Association of Antibiotic Exposure with New-Onset Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Clin Res Hepatol Gastroenterol. 2023 Apr 26:102129.
    

    >> Share

    
    March 2023
34. DE PARADES V, Fathallah N, Peyrin-Biroulet L
    The case for the prevention of fistulas in patients with perianal Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2023 Mar 21:102113.
    

    >> Share

    
    
35. BOZON A, Nancey S, Serrero M, Caillo L, et al
    Risk of Infection in Elderly Patients with Inflammatory Bowel Disease under biologics: A Prospective, Multicenter, Observational, One-Year follow-up comparative study.
    Clin Res Hepatol Gastroenterol. 2023 Mar 9:102107.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share